## 4 Discussion
\begin{table}
\begin{tabular}{l c c c c c} \hline \hline  & \multicolumn{3}{c}{**Stages**} \\ \hline
**Fatty Acids** & & **Baseline** & **Exercise\({}_{\text{only}}\)** & **Exercise\({}_{\text{+supp}}\)** & \(\eta_{p}\)\({}^{2}\)** \\ \hline Pentadeconic acid & (15:0) & 0.126 \(\pm\) 0.009 & 0.134 \(\pm\) 0.015 & 0.155 \(\pm\) 0.012 & 0.30 \\ \hline Palmitic acid & (16:0) & 22.484 \(\pm\) 0.498 & 24.159 \(\pm\) 0.279 & 22.808 \(\pm\) 0.535 & 0.08 \\ \hline Heptadeconic acid & (17:0) & 0.342 \(\pm\) 0.012 & 0.331 \(\pm\) 0.021 & 0.317 \(\pm\) 0.014 & 0.03 \\ \hline Stearic acid & (18:0) & 26.090 \(\pm\) 0.520 & 29.845 \(\pm\) 0.327 \({}^{\text{a}}\) & 29.882 \(\pm\) 0.833 \({}^{\text{a}}\) & 0.23 \\ \hline Arachidic acid & (20:0) & 0.361 \(\pm\) 0.017 & 0.409 \(\pm\) 0.015 & 0.444 \(\pm\) 0.019 \({}^{\text{a}}\) & 0.20 \\ \hline Behenic acid & (22:0) & 0.339 \(\pm\) 0.031 & 0.399 \(\pm\) 0.017 & 0.378 \(\pm\) 0.028 & 0.32 \\ \hline Trichosanoic acid & (23:0) & 0.077 \(\pm\) 0.008 & 0.112 \(\pm\) 0.008 & 0.121 \(\pm\) 0.033 & 0.70 \\ \hline Lingoseric acid & (24:0) & 0.285 \(\pm\) 0.038 & 0.339 \(\pm\) 0.020 & 0.302 \(\pm\) 0.020 & 0.36 \\ \hline Total saturated fatty acid level & (\(\Sigma\)SFA) & 50.652 \(\pm\) 1.551 & 56.473 \(\pm\) 2.014 \({}^{\text{a}}\) & 55.044 \(\pm\) 1.706 \({}^{\text{a}}\) & 0.17 \\ \hline Pentadecanoic acid & (15:1) & 0.657 \(\pm\) 0.024 & 0.815 \(\pm\) 0.024 \({}^{\text{b}}\) & 0.793 \(\pm\) 0.019 \({}^{\text{b}}\) & 0.45 \\ \hline Palmitoleic acid & (16:1) & 1.241 \(\pm\) 0.065 & 1.035 \(\pm\) 0.029 \({}^{\text{a}}\) & 0.828 \(\pm\) 0.012 \({}^{\text{b}}\) & 0.42 \\ \hline Oleic acid & (18:1n9c) & 8.665 \(\pm\) 0.241 & 7.802 \(\pm\) 0.219 & 8.195 \(\pm\) 0.395 & 0.16 \\ \hline Eicosenoic acid & (20:1n9c) & 0.135 \(\pm\) 0.009 & 0.132 \(\pm\) 0.008 & 0.139 \(\pm\) 0.005 & 0.04 \\ \hline Nervonic acid & (24:1) & 0.262 \(\pm\) 0.015 & 0.320 \(\pm\) 0.015 & 0.304 \(\pm\) 0.017 & 0.41 \\ \hline Total monounsaturated fatty acid level & (\(\sum\)MUFA) & 10.96 \(\pm\) 0.542 & 10.104 \(\pm\) 0.437 & 10.259 \(\pm\) 0.611 & 0.10 \\ \hline Linoleic acid & (18:2n6c) & 23.153 \(\pm\) 0.113 & 20.637 \(\pm\) 0.149 \({}^{\text{a}}\) & 22.174 \(\pm\) 0.120 \({}^{\text{x}}\) & 0.19 \\ \hline Linoleadic acid & (18:2n6f) & 0.033 \(\pm\) 0.002 & 0.045 \(\pm\) 0.002 \({}^{\text{a}}\) & 0.038 \(\pm\) 0.002 & 0.66 \\ \hline Gamma-linolenic acid & (18:3n6) & 0.115 \(\pm\) 0.014 & 0.069 \(\pm\) 0.008 \({}^{\text{b}}\) & 0.070 \(\pm\) 0.006 \({}^{\text{b}}\) & 0.88 \\ \hline Alpha-linolenic acid & (18:3n3) & 0.172 \(\pm\) 0.082 & 0.097 \(\pm\) 0.013 \({}^{\text{b}}\) & 0.118 \(\pm\) 0.011 \({}^{\text{b}}\) & 0.90 \\ \hline Eicosatrienoic acid & (20:3n6) & 2.034 \(\pm\) 0.191 & 1.750 \(\pm\) 0.159 \({}^{\text{a}}\) & 1.750 \(\pm\) 0.166 \({}^{\text{a}}\) & 0.30 \\ \hline Eicosenspentaenoic acid & (20:5n3) & 0.242 \(\pm\) 0.026 & 0.116 \(\pm\) 0.023 \({}^{\text{c}}\) & 0.169 \(\pm\) 0.017 \({}^{\text{a}}\) & 0.95 \\ \hline Docosahexaenoic acid & (22:6n3) & 2.520 \(\pm\) 0.066 & 1.517 \(\pm\) 0.025 \({}^{\text{a}}\) & 1.548 \(\pm\) 0.037 \({}^{\text{a}}\) & 0.88 \\ \hline Eicosadienoic acid & (20:2n6) & 0.292 \(\pm\) 0.018 & 0.278 \(\pm\) 0.019 & 0.255 \(\pm\) 0.020 & 0.11 \\ \hline Eicosaetraenoic acid & (20:4n6) & 9.827 \(\pm\) 0.265 & 8.914 \(\pm\) 0.299 & 8.575 \(\pm\) 0.431 & 0.15 \\ \hline Total polyunsaturated fatty acid level & (\(\sum\)PUFA) & 38.388 \(\pm\) 1.478 & 33.423 \(\pm\) 1.130 \({}^{\text{b}}\) & 34.697 \(\pm\) 1.342 \({}^{\text{a}}\) & 0.26 \\ \hline Total unsaturated fatty acid level & (\(\sum\)USFA) & 49.348 \(\pm\) 1.854 & 43.527 \(\pm\) 1.566 \({}^{\text{b}}\) & 44.956 \(\pm\) 1.415 \({}^{\text{a}}\) & 0.22 \\ \hline \hline \end{tabular} Comparison of other stages according to the Baseline stage. a: \(p\)\(<\) 0.05; b: \(p\)\(<\) 0.001; c: \(p\)\(<\) 0.001. Comparison of Exercise\({}_{\text{only}}\) and Exercise\({}_{\text{+supp}}\) phases. x: \(p\)\(<\) 0.05; \(\eta_{p}\)\({}^{2}\): partial eta squared.  
\end{table} 
Table 3: _Cont._TG and HDL-C [37; 38].